Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with clinical features of high metastatic potential, susceptibility to relapse, and poor prognosis. TNBC lacks the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Munkácsy, Gyöngyi, Santarpia, Libero, Győrffy, Balázs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138520/
https://www.ncbi.nlm.nih.gov/pubmed/37108109
http://dx.doi.org/10.3390/ijms24086945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138520/
https://www.ncbi.nlm.nih.gov/pubmed/37108109
http://dx.doi.org/10.3390/ijms24086945

Ejemplares similares